home / stock / nuro / nuro news

NURO News and Press, NeuroMetrix Inc. From 06/28/22

Stock Information
Company Name: NeuroMetrix Inc.
Stock Symbol: NURO
Market: NASDAQ
Website: neurometrix.com
Menu
NURO NURO Quote NURO Short NURO News NURO Articles NURO Message Board
Get NURO Alerts

News, Short Squeeze, Breakout and More Instantly...
NURO - NeuroMetrix Appoints Brad Fluegel to its Board of Directors

WOBURN, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Bradley M. Fluegel to its Board of Directors, effective as of July 1, 2022. Mr. Fluegel has a broad commercial and advisory background with concentrated industry experi...
NURO - NNVC, BEST and PYR among mid-day movers

Gainers: Leju Holdings Limited (LEJU) +47%. Redbox Entertainment (RDBX) +33%. SIGA Technologies (SIGA) +26%. Getnet (GET) +25%. Allarity (ALLR) +23%. NanoViricides (NNVC) +22%. Processa Pharmaceuticals (PCSA) +22%. TherapeuticsMD (TXMD) +17%. PyroGenesis Canada (PYR) +17%. Evofem Biosciences ...

NURO - Immix Biopharma, MDxHealth top healthcare gainers; Evofem, Bright Green lead losers' pack

Gainers: Immix Biopharma (IMMX) +48%. MDxHealth (MDXH) +31%. ClearPoint Neuro (CLPT) +16%. Covetrus (CVET) +14%. Kronos Bio (KRON) +13%. Losers: Evofem Biosciences (EVFM) -58%. Bright Green (BGXX) -26%. Foghorn Therapeutics (FHTX) -19%. N...

NURO - UPST, NOVN and BURL among pre market losers

Evofem Biosciences (EVFM) -43% on planned public offering. Ross Stores (ROST) -23% on Q1 results. Bright Green (BGXX) -12%. NeuroMetrix (NURO) -10%. Burlington Stores (BURL) -10%. Novan, Inc. (NOVN) -8%. Upstart Holdings (UPST) -7% Saxena White P.A. files new securiti...
NURO - Hot Penny Stocks to Watch Right Now? 3 For Your List in May

3 Penny Stocks to Add to Your Watchlist Today With a relatively flat day of trading for penny stocks and blue chips, there are plenty of opportunities for investors right now. Although trading penny stocks can be challenging, it can also be highly rewarding if done correctly. Fo...

NURO - Why Is NeuroMetrix (NURO) Stock Up 70% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NeuroMetrix (NASDAQ: NURO ) announced a special U.S. Food and Drug Administration designation for its Quell device This wearable technology is aimed at patients with fibromyalgia NURO stock has surged 70% on anti...

NURO - CIG, BTCM and CYAD among mid-day movers

Gainers: NeuroMetrix (NURO) +34%. Millicom International (TIGO) +32%. Grab Holdings (GRAB) +30%. SIGA Technologies (SIGA) +26%. Celyad Oncology (CYAD) +19%. Clene (CLNN) +19%. Applied Blockchain (APLD) +19%. Immunome (IMNM) +18%. BIT Mining (BTCM) +18%. Losers: Companhia Energetica de Minas G...
NURO - NeuroMetrix, Zealand Pharma top healthcare gainers; China SXT, Ocuphire lead losers' pack

Gainers: NeuroMetrix (NURO) +45%. Zealand Pharma (ZEAL) +18%. SIGA Technologies (SIGA) +16%. Indaptus Therapeutics (INDP) +15%. Immix Biopharma (IMMX) +13%. Losers: China SXT Pharmaceuticals (SXTC) -20%. Ocuphire Pharma (OCUP) -9%. Enanta Pharmaceu...

NURO - NeuroMetrix wins approval of neuromodulation device for fibromyalgia; shares up 42%

The U.S. FDA granted De Novo authorization to NeuroMetrix (NASDAQ:NURO) for its Quell neuromodulation device used to treat fibromyalgia. Shares are up 42% in premarket trading. Quell is the first non-pharmacological treatment for the condition approved by the agency. Quell is c...

NURO - NeuroMetrix Reports that Quell® Wearable Neuromodulation Device has Received FDA De Novo Authorization as First Non-Pharmacological Treatment for Fibromyalgia

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced U.S. Food and Drug Administration (FDA) De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity....
Previous 10 Next 10